Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis
- 28 April 2009
- journal article
- Published by Wiley in European Journal of Neurology
- Vol. 16 (6), 771-774
- https://doi.org/10.1111/j.1468-1331.2009.02560.x
Abstract
Background and purpose: Amyotrophic lateral sclerosis (ALS) is classically assumed to be a neurodegenerative disorder. Inflammation has been observed in CNS tissue in ALS patients. We investigated the expression and prognostic relevance of proinflammatory chemokines in ALS. Methods: We analyzed nine chemokines, eotaxin, eotaxin-3, IL-8, IP-10, MCP-1, MCP-4, macrophage derived chemokine (MDC), macrophage inflammatory protein-1β (MIP-1β), and serum thymus and activation- regulated chemokine (TARC) in serum and cerebrospinal fluid (CSF) of 20 ALS- and 20 non-inflammatory neurological disease (NIND)-patients. Results: MCP-1 and IL-8 levels in CSF in ALS were significantly higher than in NIND (1304 pg/ml vs. 1055 pg/ml, P = 0.013 and 22.7 pg/ml vs. 18.6 pg/ml, P = 0.035). The expression of MCP-1 and IL-8 were higher in CSF than in serum (P < 0.001). There was a trend towards higher MCP-1 CSF levels in ALS patients with shorter time between first symptoms and diagnosis (r = −0.407; P = 0.075). Conclusions: We confirmed previous findings of increased MCP-1 levels in CSF of ALS patients. Furthermore, increased levels of IL-8 in CSF suggest a stimulation of a proinflammatory cytokine cascade after microglia activation. We found a tendency for higher MCP-1 values in patients with a shorter diagnostic delay, who are known to have also a shorter survival. This may suggest an association of higher MCP-1 levels with rapidly progressing disease.This publication has 17 references indexed in Scilit:
- How chemokines invite leukocytes to danceNature Immunology, 2008
- Chemokines and leukocyte trafficNature Immunology, 2008
- Innate immunity in amyotrophic lateral sclerosisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2006
- Predictability of disease progression in amyotrophic lateral sclerosisMuscle & Nerve, 2006
- Intrathecal Upregulation of Granulocyte Colony Stimulating Factor and Its Neuroprotective Actions on Motor Neurons in Amyotrophic Lateral SclerosisJournal of Neuropathology and Experimental Neurology, 2006
- The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALSMolecular and Cellular Neuroscience, 2006
- The Many Roles of Chemokines and Chemokine Receptors in InflammationThe New England Journal of Medicine, 2006
- Production of monocyte chemoattractant protein‐1 in amyotrophic lateral sclerosisMuscle & Nerve, 2005
- Presence of dendritic cells, MCP‐1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissueAnnals of Neurology, 2003
- Intrathecal synthesis of monocyte chemoattractant protein-1 (MCP-1) in amyotrophic lateral sclerosis: further evidence for microglial activation in neurodegenerationJournal of Neuroimmunology, 2003